End-of-life note GenoFAB operations concluded on September 1, 2025, with GenoCAD maintained only for archival reference. This signals a potential shift in needs for customers seeking ongoing plasmid sourcing, sequencing, and design services, creating opportunities to engage former GenoFAB clients or adjacent biotech teams requiring continuity solutions.

Plasmid catalog value GenoCAD offers a growing catalog of classic and TrueVector plasmids, with most items shipping within one business day and options for gene inserts. This presents a selling point for teams seeking rapid procurement, scalable constructs, and ready-to-use vectors, particularly for high-throughput or time-sensitive projects.

Custom design services Premium design, synthesis, and purification services for non-standard plasmids highlight a cross-sell opportunity to researchers needing tailored constructs, potentially expanding into partnerships with gene therapy developers and biomanufacturers seeking end-to-end plasmid solutions.

New sequencing service GenoFAB launched a whole plasmid sequencing service in February 2025 to improve reproducibility and quality control. This opens doors for collaboration with labs prioritizing documentation, traceability, and regulatory readiness, including contract research organizations and quality-focused biotechs.

Technology and ecosystem The tech stack (Power BI, WordPress, Salesforce, OpenAI, SEMrush, PayPal, Heroku, Moz) indicates a modern, data-driven sales and marketing operation with potential for targeted outreach, automated workflows, and enhanced customer insights to identify and convert interested scientists and organizations in biotechnology research, clinical development, and biomanufacturing.